SS
BCAB icon

SBI Securities’s BioAtla BCAB Stock Holding History

SBI Securities’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.79K Buy
222
+46
+26% +$538 ﹤0.01% 2459
2025
Q4 		$4.99K Buy
176
+27
+18% +$1.06K ﹤0.01% 2024
2025
Q3 		$5.13K Buy
149
+29
+24% +$670 ﹤0.01% 2035
2025
Q2 		$2.38K Buy
120
+38
+46% +$771 ﹤0.01% 2315
2025
Q1 		$1.43K Buy
82
+65
+382% +$1.39K ﹤0.01% 2437
2024
Q4 		$488 Buy
+17
New +$1.43K ﹤0.01% 2896

Other funds holding BCAB

ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SBI Securities's BCAB Position: Q1 2026 in Review

SBI Securities increased its BioAtla (BCAB) stake by 26% in Q1 2026, buying an estimated $538 and bringing the position to 222 shares worth $1.79K. The position accounts for ﹤0.01% of the portfolio, ranked #2459.

SBI Securities first reported a position in BCAB in Q4 2024 and has held it in 6 quarters since. The position peaked at $5.13K in Q3 2025. 36 funds tracked by Wall St. Rank hold BCAB as of Q1 2026.

  • SBI Securities held 222 shares of BioAtla worth $1.79K as of Q1 2026.
  • SBI Securities bought 46 BioAtla shares in Q1 2026, an estimated $538.
  • BioAtla made up ﹤0.01% of SBI Securities's portfolio in Q1 2026, its #2459 holding.
  • SBI Securities first reported a position in BioAtla in Q4 2024 and has held it in 6 quarters since.
  • SBI Securities's BioAtla position peaked at $5.13K in Q3 2025.
  • 36 funds tracked by Wall St. Rank held BioAtla as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.